ATE493656T1 - Verfahren zur diagnose von multipler sklerose - Google Patents

Verfahren zur diagnose von multipler sklerose

Info

Publication number
ATE493656T1
ATE493656T1 AT06765559T AT06765559T ATE493656T1 AT E493656 T1 ATE493656 T1 AT E493656T1 AT 06765559 T AT06765559 T AT 06765559T AT 06765559 T AT06765559 T AT 06765559T AT E493656 T1 ATE493656 T1 AT E493656T1
Authority
AT
Austria
Prior art keywords
multiple sclerosis
diagnosing multiple
diagnosing
reagent
application
Prior art date
Application number
AT06765559T
Other languages
English (en)
Inventor
Nir Dotan
Avinoam Dukler
Mikael Scwartz
Original Assignee
Glycominds Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycominds Ltd filed Critical Glycominds Ltd
Application granted granted Critical
Publication of ATE493656T1 publication Critical patent/ATE493656T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Testing Of Engines (AREA)
  • Heat Treatment Of Steel (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Control Of Electric Motors In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06765559T 2005-01-31 2006-01-31 Verfahren zur diagnose von multipler sklerose ATE493656T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/047,124 US7572592B2 (en) 2005-01-31 2005-01-31 Method for diagnosing multiple sclerosis
PCT/IB2006/001656 WO2006117689A2 (en) 2005-01-31 2006-01-31 Method for diagnosing multiple sclerosis

Publications (1)

Publication Number Publication Date
ATE493656T1 true ATE493656T1 (de) 2011-01-15

Family

ID=36757039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06765559T ATE493656T1 (de) 2005-01-31 2006-01-31 Verfahren zur diagnose von multipler sklerose

Country Status (15)

Country Link
US (4) US7572592B2 (de)
EP (1) EP1856531B1 (de)
AT (1) ATE493656T1 (de)
AU (1) AU2006242939B2 (de)
CA (1) CA2595277A1 (de)
CY (1) CY1111839T1 (de)
DE (1) DE602006019206D1 (de)
DK (1) DK1856531T3 (de)
ES (1) ES2358606T3 (de)
IL (1) IL184905A (de)
NZ (1) NZ560978A (de)
PL (1) PL1856531T3 (de)
PT (1) PT1856531E (de)
SI (1) SI1856531T1 (de)
WO (1) WO2006117689A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL210512B1 (pl) * 2002-08-02 2012-01-31 Glycominds Ltd Sposób, zestaw i podłoże do diagnozowania stwardnienia rozsianego
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US8216791B2 (en) * 2005-01-31 2012-07-10 Glycominds Ltd. Method for diagnosing multiple sclerosis
AU2007337823A1 (en) * 2006-08-29 2008-07-03 Glycominds Ltd Method of diagnosing and stratifying anti-phospholipid syndrome
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
EP2353004B1 (de) 2008-11-12 2018-01-03 Yeda Research and Development Co. Ltd. Diagnose multipler sklerose
US20100203569A1 (en) * 2009-02-12 2010-08-12 Glycominks LTD Method for Evaluating Risk in Multiple Sclerosis
US20120190581A1 (en) * 2009-08-25 2012-07-26 The Johns Hopkins University Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
SG10201505723UA (en) 2010-07-23 2015-09-29 Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
EA201590024A1 (ru) 2012-06-15 2015-05-29 Гарри Стилли Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2015089443A2 (en) * 2013-12-12 2015-06-18 The Brigham And Women's Hospital, Inc. Treating neurodegenerative disease
EP4428251A3 (de) 2014-09-11 2024-12-18 Immunis.AI, Inc. Verfahren zum nachweis von prostatakrebs
US10495646B2 (en) 2015-01-30 2019-12-03 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of MS disease course
US10538794B2 (en) 2016-11-29 2020-01-21 Emory University Oligosaccharide libraries and methods of production
EP3401682A1 (de) 2017-05-09 2018-11-14 Université de Nantes Diagnose, vorbeugung und behandlung von demyelinisierenden erkrankungen des zentralen nervensystems
WO2021158843A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158847A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158841A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158845A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
WO2021158839A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator
US11135197B2 (en) 2020-02-07 2021-10-05 Argentum Pharmaceuticals Llc Dosage regimen of an S1P receptor modulator
WO2021158844A1 (en) * 2020-02-07 2021-08-12 Argentum Pharmaceuticals Llc Treatment and dosing regimen for s1p receptor modulator

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030560A (en) * 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
US6994966B2 (en) 2000-02-17 2006-02-07 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
HUP0200814A3 (en) 1999-02-17 2003-01-28 Glycominds Ltd Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US20010051349A1 (en) 2000-02-17 2001-12-13 Glycominds Ltd. Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
US6762032B1 (en) 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
JP2003519784A (ja) 2000-01-10 2003-06-24 ゲノスペクトラ・インク 線形プローブキャリア
AU2001288431A1 (en) 2000-08-28 2002-03-13 The Trustees Of Columbia University In The City Of New York Detection of anti-glycolipid antibodies by latex agglutination assay
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
US20040241763A1 (en) * 2002-08-02 2004-12-02 Nir Dotan Method for diagnosing multiple sclerosis
PL210512B1 (pl) * 2002-08-02 2012-01-31 Glycominds Ltd Sposób, zestaw i podłoże do diagnozowania stwardnienia rozsianego
WO2004034031A2 (en) 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis

Also Published As

Publication number Publication date
PT1856531E (pt) 2011-03-24
DK1856531T3 (da) 2011-04-18
EP1856531B1 (de) 2010-12-29
US20090291456A1 (en) 2009-11-26
PL1856531T3 (pl) 2011-07-29
CY1111839T1 (el) 2015-10-07
EP1856531A2 (de) 2007-11-21
US7906291B2 (en) 2011-03-15
AU2006242939A1 (en) 2006-11-09
ES2358606T3 (es) 2011-05-12
US20060234301A1 (en) 2006-10-19
US20060172338A1 (en) 2006-08-03
US8129128B2 (en) 2012-03-06
IL184905A (en) 2012-02-29
US20110092383A1 (en) 2011-04-21
SI1856531T1 (sl) 2011-05-31
AU2006242939B2 (en) 2012-04-19
IL184905A0 (en) 2007-12-03
CA2595277A1 (en) 2006-11-09
US7572592B2 (en) 2009-08-11
WO2006117689A3 (en) 2007-01-25
WO2006117689A2 (en) 2006-11-09
DE602006019206D1 (de) 2011-02-10
NZ560978A (en) 2010-12-24

Similar Documents

Publication Publication Date Title
DE602006019206D1 (de) Verfahren zur diagnose von multipler sklerose
EP3293200C0 (de) Verfahren für die entwicklung von immunoglobulinen
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
EP2074380A4 (de) Verfahren zur analyse einer fahrzeugumgebung
ATE527542T1 (de) Verfahren zur herstellung von abbildungssonden unter verwendung von click chemie
DE602006014260D1 (de) Verfahren zur analyse einer blutprobe
ATE480642T1 (de) Verfahren zur bestimmung von genotoxizität
DE602004020550D1 (de) Verfahren zur Untersuchung von Halbleitern
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
ATE479100T1 (de) Verfahren zur diagnose von lawsonia intracellularis
DE602008000683D1 (de) Immunassay-Verfahren, Reagenzienkit zur Erkennung einer Alkali-Phosphatase und Reagenzienkit für das Immunassay-Verfahren
ATE376672T1 (de) Verfahren zur diagnose von multipler sklerose
DE602005001409D1 (de) Verfahren zur Verbesserung der Leistung von organischen Beschichtungen für Korrosionsbeständigkeit
TR201900481T4 (tr) Bağışıklık testi için aparat ve kit.
DE60322768D1 (de) Verfahren zur Herstellung von Partikeln für ein diagnostisches Reagenz
MX2009005630A (es) Metodo para analizar datos de imagenes relacionados con ensayos de aglutinacion.
DE602006020904D1 (de) Verfahren zum testen von antigen
DK1864131T3 (da) Naturlig ligand af G protein koblet receptor RCC356 og anvendelser deraf
DE502006007045D1 (de) Verfahren zur herstellung von nitrilen durch eliminierungsreaktionen
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
FR2938648B1 (fr) Procede d'evaluation du vieillissement d'un ensemble electronique
EP1901066A4 (de) Verfahren zur diagnose von morbus alzheimer unter verwendung von serumglykoprotein als biomarker
DE112006000481A5 (de) Verfahren zur Bestimmung der elastischen Verformung von Bauteilen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1856531

Country of ref document: EP